Sandra F Simmons1,2,3, Kemberlee R Bonnett4, Emily Hollingsworth1,2, Jennifer Kim5, James Powers2,3, Ralf Habermann2, Paul Newhouse3,6, David G Schlundt4. 1. Center for Quality Aging, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. 2. Division of Geriatrics, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. 3. Geriatric Research, Education and Clinical Center (GRECC), VA Tennessee Valley Healthcare System, Nashville. 4. Department of Psychology, Vanderbilt University, Nashville, Tennessee. 5. School of Nursing, Vanderbilt University, Nashville, Tennessee. 6. Center for Cognitive Medicine, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
Background and Objectives: The purpose of this study was to use qualitative methods to explore nursing home staff perceptions of antipsychotic medication use and identify both benefits and barriers to reducing inappropriate use from their perspective. Research Design and Methods: Focus groups were conducted with a total of 29 staff in three community nursing homes that served both short and long-stay resident populations. Results: The majority (69%) of the staff participants were licensed nurses. Participants expressed many potential benefits of antipsychotic medication reduction with four primary themes: (a) Improvement in quality of life, (b) Improvement in family satisfaction, (c) Reduction in falls, and (d) Improvement in the facility Quality Indicator score (regulatory compliance). Participants also highlighted important barriers they face when attempting to reduce or withdraw antipsychotic medications including: (a) Family resistance, (b) Potential for worsening or return of symptoms or behaviors, (c) Lack of effectiveness and/or lack of staff resources to consistently implement nonpharmacological management strategies, and (d) Risk aversion of staff and environmental safety concerns. Discussion and Implications: Nursing home staff recognize the value of reducing antipsychotic medications; however, they also experience multiple barriers to reduction in routine clinical practice. Achievement of further reductions in antipsychotic medication use will require significant additional efforts and adequate clinical personnel to address these barriers.
Background and Objectives: The purpose of this study was to use qualitative methods to explore nursing home staff perceptions of antipsychotic medication use and identify both benefits and barriers to reducing inappropriate use from their perspective. Research Design and Methods: Focus groups were conducted with a total of 29 staff in three community nursing homes that served both short and long-stay resident populations. Results: The majority (69%) of the staff participants were licensed nurses. Participants expressed many potential benefits of antipsychotic medication reduction with four primary themes: (a) Improvement in quality of life, (b) Improvement in family satisfaction, (c) Reduction in falls, and (d) Improvement in the facility Quality Indicator score (regulatory compliance). Participants also highlighted important barriers they face when attempting to reduce or withdraw antipsychotic medications including: (a) Family resistance, (b) Potential for worsening or return of symptoms or behaviors, (c) Lack of effectiveness and/or lack of staff resources to consistently implement nonpharmacological management strategies, and (d) Risk aversion of staff and environmental safety concerns. Discussion and Implications: Nursing home staff recognize the value of reducing antipsychotic medications; however, they also experience multiple barriers to reduction in routine clinical practice. Achievement of further reductions in antipsychotic medication use will require significant additional efforts and adequate clinical personnel to address these barriers.
Authors: Lauren B Gerlach; Donovan T Maust; Helen C Kales; Myron Chang; H Myra Kim; Ilse R Wiechers; Kara Zivin Journal: Am J Psychiatry Date: 2022-05-26 Impact factor: 19.242
Authors: Tingzhong Michelle Xue; Cathleen S Colón-Emeric; Laurie Herndon; Emily J Hecker; Sarah D Berry; Milta O Little; Eleanor S McConnell Journal: Gerontologist Date: 2022-09-07
Authors: Daniel J Hoyle; Ivan K Bindoff; Lisa M Clinnick; Gregory M Peterson; Juanita L Westbury Journal: Drugs Aging Date: 2018-02 Impact factor: 3.923
Authors: Sarita Y Lo; Emily Reeve; Amy T Page; Syed Tabish R Zaidi; Sarah N Hilmer; Christopher Etherton-Beer; Andrew McLachlan; Lisa Pont; Vasi Naganathan Journal: Drugs Aging Date: 2021-06-25 Impact factor: 3.923